237 related articles for article (PubMed ID: 25930097)
1. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.
Shin EJ; Topazian M; Goggins MG; Syngal S; Saltzman JR; Lee JH; Farrell JJ; Canto MI
Gastrointest Endosc; 2015 Nov; 82(5):812-8. PubMed ID: 25930097
[TBL] [Abstract][Full Text] [Related]
2. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial.
Gangi A; Malafa M; Klapman J
Pancreas; 2018; 47(5):586-591. PubMed ID: 29683970
[TBL] [Abstract][Full Text] [Related]
4. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
5. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
[TBL] [Abstract][Full Text] [Related]
6. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
Khashab MA; Yong E; Lennon AM; Shin EJ; Amateau S; Hruban RH; Olino K; Giday S; Fishman EK; Wolfgang CL; Edil BH; Makary M; Canto MI
Gastrointest Endosc; 2011 Apr; 73(4):691-6. PubMed ID: 21067742
[TBL] [Abstract][Full Text] [Related]
7. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
Agarwal B; Krishna NB; Labundy JL; Safdar R; Akduman EI
Gastrointest Endosc; 2008 Aug; 68(2):237-42; quiz 334, 335. PubMed ID: 18423464
[TBL] [Abstract][Full Text] [Related]
8. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer--EUS and early diagnosis.
Helmstaedter L; Riemann JF
Langenbecks Arch Surg; 2008 Nov; 393(6):923-7. PubMed ID: 18247044
[TBL] [Abstract][Full Text] [Related]
10. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
11. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
12. Radial scanning and linear array endosonography for staging pancreatic cancer: a prospective randomized comparison.
Gress F; Savides T; Cummings O; Sherman S; Lehman G; Zaidi S; Hawes R
Gastrointest Endosc; 1997 Feb; 45(2):138-42. PubMed ID: 9040998
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
Daskalakis K; Tsoli M; Alexandraki KI; Angelousi A; Chatzellis E; Tsolakis AV; Karoumpalis I; Kolomodi D; Kassi E; Kaltsas G
Horm Metab Res; 2019 Sep; 51(9):580-585. PubMed ID: 31295747
[TBL] [Abstract][Full Text] [Related]
14. Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of Recurrence in the Remnant Pancreas.
Ikemoto J; Hanada K; Minami T; Okazaki A; Abe T; Amano H; Yonehara S
Pancreas; 2018 Apr; 47(4):482-488. PubMed ID: 29517631
[TBL] [Abstract][Full Text] [Related]
15. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer.
Sanders MK; Moser AJ; Khalid A; Fasanella KE; Zeh HJ; Burton S; McGrath K
Gastrointest Endosc; 2010 Jun; 71(7):1178-84. PubMed ID: 20362284
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.
Napoleon B; Alvarez-Sanchez MV; Gincoul R; Pujol B; Lefort C; Lepilliez V; Labadie M; Souquet JC; Queneau PE; Scoazec JY; Chayvialle JA; Ponchon T
Endoscopy; 2010 Jul; 42(7):564-70. PubMed ID: 20593334
[TBL] [Abstract][Full Text] [Related]
17. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional linear endoscopic ultrasound-feasibility of a novel technique applied for the detection of vessel involvement of pancreatic masses.
Fritscher-Ravens A; Knoefel WT; Krause C; Swain CP; Brandt L; Patel K
Am J Gastroenterol; 2005 Jun; 100(6):1296-302. PubMed ID: 15929760
[TBL] [Abstract][Full Text] [Related]
19. Potential value of EUS in pancreatic surveillance of VHL patients.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis.
Kogekar N; Diaz KE; Weinberg AD; Lucas AL
Pancreatology; 2020 Dec; 20(8):1739-1746. PubMed ID: 33077384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
